Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title | FOA | Organization | Release Date | Expire Date Sort descending | Purpose |
---|---|---|---|---|---|
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) | PAR-23-097 | NIMH | The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized… More | ||
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) | PAR-21-353 | NICHD | This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through… More | ||
Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) | PAR-22-053 | NINDS | Functional Neurological Disorders (FNDs) are characterized by symptoms of altered voluntary motor or sensory function with clinical findings providing evidence of incompatibility between the symptoms… More | ||
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) | PAR-22-047 | NIA | The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug… More | ||
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | PAR-21-329 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic… More | ||
NCI Outstanding Investigator Award (R35 Clinical Trial Optional) | RFA-CA-22-045 | NCI | This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.The objective of the National Cancer Institute (NCI… More | ||
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) | PAR-21-295 | NCI | This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded… More | ||
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) | PAR-21-296 | NCI | This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded… More | ||
Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) | RFA-DA-23-008 | NIDA | Stimulant use has been increasing among opioid users since 2016, based on overdose data and this makes control of the opioid epidemic more difficult, as it occurs in addition to the continuing influx… More | ||
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) | PAR-22-094 | NIA | The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease (AD) and its… More |